Global Paclitaxel Injection Market Research Report 2025

Publication ID:

PB504255081

Publication Date:

April 30, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Paclitaxel Injection was valued at US$ 4170 million in the year 2024 and is projected to reach a revised size of US$ 8626 million by 2031, growing at a CAGR of 11.1% during the forecast period.
Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.
Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi"s sarcoma, it may be given once every 2 or 3 weeks.
Global Paclitaxel Injection key players include Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E., Luye Pharma, etc. Global top five players hold a share about 80%.
Europe is the largest market, with a share about 25%, followed by North America and China, having a total share about 40 percent.
In terms of product, 5ml,30mg is the largest segment, with a share about 75%. And in terms of application, the largest application is Ovarian Cancer, followed by Breast Cancer, Cervical Cancer, Pancreatic Cancer.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Paclitaxel Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paclitaxel Injection.
The Paclitaxel Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Paclitaxel Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paclitaxel Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bristol-Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Khandelwal Laboratories
Luye Pharma
Beijing Youcare
Beijing Union
Haiyao
Chuntch
Segment by Type
5ml,30mg
10ml,60mg
16.7ml,100mg
25ml,150mg
50ml,300mg
Segment by Application
Ovarian Cancer
Breast Cancer
Cervical Cancer
Pancreatic Cancer
Other
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Paclitaxel Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Paclitaxel Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Paclitaxel Injection Market Overview
1.1 Product Definition
1.2 Paclitaxel Injection by Type
1.2.1 Global Paclitaxel Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 5ml,30mg
1.2.3 10ml,60mg
1.2.4 16.7ml,100mg
1.2.5 25ml,150mg
1.2.6 50ml,300mg
1.3 Paclitaxel Injection by Application
1.3.1 Global Paclitaxel Injection Market Value by Application (2024 VS 2031)
1.3.2 Ovarian Cancer
1.3.3 Breast Cancer
1.3.4 Cervical Cancer
1.3.5 Pancreatic Cancer
1.3.6 Other
1.4 Global Paclitaxel Injection Market Size Estimates and Forecasts
1.4.1 Global Paclitaxel Injection Revenue 2020-2031
1.4.2 Global Paclitaxel Injection Sales 2020-2031
1.4.3 Global Paclitaxel Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Paclitaxel Injection Market Competition by Manufacturers
2.1 Global Paclitaxel Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Paclitaxel Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Paclitaxel Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Paclitaxel Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Paclitaxel Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Paclitaxel Injection, Product Type & Application
2.7 Global Key Manufacturers of Paclitaxel Injection, Date of Enter into This Industry
2.8 Global Paclitaxel Injection Market Competitive Situation and Trends
2.8.1 Global Paclitaxel Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Paclitaxel Injection Players Market Share by Revenue
2.8.3 Global Paclitaxel Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Paclitaxel Injection Market Scenario by Region
3.1 Global Paclitaxel Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Paclitaxel Injection Sales by Region: 2020-2031
3.2.1 Global Paclitaxel Injection Sales by Region: 2020-2025
3.2.2 Global Paclitaxel Injection Sales by Region: 2026-2031
3.3 Global Paclitaxel Injection Revenue by Region: 2020-2031
3.3.1 Global Paclitaxel Injection Revenue by Region: 2020-2025
3.3.2 Global Paclitaxel Injection Revenue by Region: 2026-2031
3.4 North America Paclitaxel Injection Market Facts & Figures by Country
3.4.1 North America Paclitaxel Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Paclitaxel Injection Sales by Country (2020-2031)
3.4.3 North America Paclitaxel Injection Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Paclitaxel Injection Market Facts & Figures by Country
3.5.1 Europe Paclitaxel Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Paclitaxel Injection Sales by Country (2020-2031)
3.5.3 Europe Paclitaxel Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Paclitaxel Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Paclitaxel Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Paclitaxel Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Paclitaxel Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Paclitaxel Injection Market Facts & Figures by Country
3.7.1 Latin America Paclitaxel Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Paclitaxel Injection Sales by Country (2020-2031)
3.7.3 Latin America Paclitaxel Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Paclitaxel Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Paclitaxel Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Paclitaxel Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Paclitaxel Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Paclitaxel Injection Sales by Type (2020-2031)
4.1.1 Global Paclitaxel Injection Sales by Type (2020-2025)
4.1.2 Global Paclitaxel Injection Sales by Type (2026-2031)
4.1.3 Global Paclitaxel Injection Sales Market Share by Type (2020-2031)
4.2 Global Paclitaxel Injection Revenue by Type (2020-2031)
4.2.1 Global Paclitaxel Injection Revenue by Type (2020-2025)
4.2.2 Global Paclitaxel Injection Revenue by Type (2026-2031)
4.2.3 Global Paclitaxel Injection Revenue Market Share by Type (2020-2031)
4.3 Global Paclitaxel Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Paclitaxel Injection Sales by Application (2020-2031)
5.1.1 Global Paclitaxel Injection Sales by Application (2020-2025)
5.1.2 Global Paclitaxel Injection Sales by Application (2026-2031)
5.1.3 Global Paclitaxel Injection Sales Market Share by Application (2020-2031)
5.2 Global Paclitaxel Injection Revenue by Application (2020-2031)
5.2.1 Global Paclitaxel Injection Revenue by Application (2020-2025)
5.2.2 Global Paclitaxel Injection Revenue by Application (2026-2031)
5.2.3 Global Paclitaxel Injection Revenue Market Share by Application (2020-2031)
5.3 Global Paclitaxel Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Company Information
6.1.2 Bristol-Myers Squibb Description and Business Overview
6.1.3 Bristol-Myers Squibb Paclitaxel Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bristol-Myers Squibb Paclitaxel Injection Product Portfolio
6.1.5 Bristol-Myers Squibb Recent Developments/Updates
6.2 Celgene Corporation
6.2.1 Celgene Corporation Company Information
6.2.2 Celgene Corporation Description and Business Overview
6.2.3 Celgene Corporation Paclitaxel Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Celgene Corporation Paclitaxel Injection Product Portfolio
6.2.5 Celgene Corporation Recent Developments/Updates
6.3 Hospira
6.3.1 Hospira Company Information
6.3.2 Hospira Description and Business Overview
6.3.3 Hospira Paclitaxel Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hospira Paclitaxel Injection Product Portfolio
6.3.5 Hospira Recent Developments/Updates
6.4 Biological E.
6.4.1 Biological E. Company Information
6.4.2 Biological E. Description and Business Overview
6.4.3 Biological E. Paclitaxel Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biological E. Paclitaxel Injection Product Portfolio
6.4.5 Biological E. Recent Developments/Updates
6.5 Taj Accura
6.5.1 Taj Accura Company Information
6.5.2 Taj Accura Description and Business Overview
6.5.3 Taj Accura Paclitaxel Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Taj Accura Paclitaxel Injection Product Portfolio
6.5.5 Taj Accura Recent Developments/Updates
6.6 Khandelwal Laboratories
6.6.1 Khandelwal Laboratories Company Information
6.6.2 Khandelwal Laboratories Description and Business Overview
6.6.3 Khandelwal Laboratories Paclitaxel Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Khandelwal Laboratories Paclitaxel Injection Product Portfolio
6.6.5 Khandelwal Laboratories Recent Developments/Updates
6.7 Luye Pharma
6.7.1 Luye Pharma Company Information
6.7.2 Luye Pharma Description and Business Overview
6.7.3 Luye Pharma Paclitaxel Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Luye Pharma Paclitaxel Injection Product Portfolio
6.7.5 Luye Pharma Recent Developments/Updates
6.8 Beijing Youcare
6.8.1 Beijing Youcare Company Information
6.8.2 Beijing Youcare Description and Business Overview
6.8.3 Beijing Youcare Paclitaxel Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Beijing Youcare Paclitaxel Injection Product Portfolio
6.8.5 Beijing Youcare Recent Developments/Updates
6.9 Beijing Union
6.9.1 Beijing Union Company Information
6.9.2 Beijing Union Description and Business Overview
6.9.3 Beijing Union Paclitaxel Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Beijing Union Paclitaxel Injection Product Portfolio
6.9.5 Beijing Union Recent Developments/Updates
6.10 Haiyao
6.10.1 Haiyao Company Information
6.10.2 Haiyao Description and Business Overview
6.10.3 Haiyao Paclitaxel Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Haiyao Paclitaxel Injection Product Portfolio
6.10.5 Haiyao Recent Developments/Updates
6.11 Chuntch
6.11.1 Chuntch Company Information
6.11.2 Chuntch Description and Business Overview
6.11.3 Chuntch Paclitaxel Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Chuntch Paclitaxel Injection Product Portfolio
6.11.5 Chuntch Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Paclitaxel Injection Industry Chain Analysis
7.2 Paclitaxel Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Paclitaxel Injection Production Mode & Process Analysis
7.4 Paclitaxel Injection Sales and Marketing
7.4.1 Paclitaxel Injection Sales Channels
7.4.2 Paclitaxel Injection Distributors
7.5 Paclitaxel Injection Customer Analysis
8 Paclitaxel Injection Market Dynamics
8.1 Paclitaxel Injection Industry Trends
8.2 Paclitaxel Injection Market Drivers
8.3 Paclitaxel Injection Market Challenges
8.4 Paclitaxel Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Bristol-Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Khandelwal Laboratories
Luye Pharma
Beijing Youcare
Beijing Union
Haiyao
Chuntch

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂